From robotic screenings to DNA editing treatments, technology can do remarkable things in healthcare.
But despite a surge in powerful scientific tools over recent decades, pharmaceutical R&D productivity has continued to decline.
The industry is approaching one of the largest patent cliffs in its history, with many blockbuster medicines set to lose exclusivity over the next decade.
Check out the rest of the feature here
